1. 1048OM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients (pts) with advanced SCCHN: Results from a phase I cohort. (23rd October 2018) Authors: Cho, B C; Daste, A; Ravaud, A; Salas, S; Isambert, N; McClay, E; Awada, A; Borel, C; Gulley, J; Ojalvo, L; Helwig, C; Rolfe, P A; Penel, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 643PM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with post-platinum esophageal adenocarcinoma (EAC): Preliminary results from a phase I cohort. (23rd October 2018) Authors: Tan, B; Khattak, A; Felip, E; Kelly, K; Rich, P; Wang, D; Helwig, C; Dussault, I; Ojalvo, L; Isambert, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗